These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25592070)

  • 1. Substantia nigra echogenicity in hereditary ataxias with and without nigrostriatal pathology: a pilot study.
    Martínez-Sánchez P; Cazorla-García R; Sanz-Gallego I; Correas-Callero E; Pulido-Valdeolivas I; Arpa J
    Cerebellum; 2015 Jun; 14(3):240-6. PubMed ID: 25592070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound.
    Berg D; Becker G; Zeiler B; Tucha O; Hofmann E; Preier M; Benz P; Jost W; Reiners K; Lange KW
    Neurology; 1999 Sep; 53(5):1026-31. PubMed ID: 10496262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial sonography findings in spinocerebellar ataxia type 3 (Machado-Joseph disease): a cross-sectional study.
    Pedroso JL; Bor-Seng-Shu E; Felício AC; Braga-Neto P; Teixeira MJ; Barsottini OG
    Neurosci Lett; 2011 Oct; 504(2):98-101. PubMed ID: 21939734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.
    Berg D; Roggendorf W; Schröder U; Klein R; Tatschner T; Benz P; Tucha O; Preier M; Lange KW; Reiners K; Gerlach M; Becker G
    Arch Neurol; 2002 Jun; 59(6):999-1005. PubMed ID: 12056937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease.
    Pedroso JL; Bor-Seng-Shu E; Felício AC; Braga-Neto P; Hoexter MQ; Teixeira MJ; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2013 Aug; 19(8):742-5. PubMed ID: 23680416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial sonography in ataxia.
    Krogias C; Postert T; Eyding J
    Int Rev Neurobiol; 2010; 90():217-35. PubMed ID: 20692505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
    Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
    Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristic and biomarker value of transcranial sonography in cerebellar ataxia.
    Zhu S; Shi Y; Chen Z; Long Z; Wan L; Chen D; Yuan X; Fu Y; Deng F; Long X; Du K; Qiu R; Tang B; Wang C; Jiang H
    Ann Clin Transl Neurol; 2024 Aug; 11(8):2100-2111. PubMed ID: 38924300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
    Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
    J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra echogenicity in Friedreich's ataxia patients.
    Sierra M; Infante J; Berciano J
    Cerebellum; 2013 Aug; 12(4):437-40. PubMed ID: 23239281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6.
    Kim JM; Lee JY; Kim HJ; Kim JS; Kim YK; Park SS; Kim SE; Jeon BS
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):529-32. PubMed ID: 20460591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial sonography in spinocerebellar ataxia type 2.
    Mijajlović M; Dragasević N; Stefanova E; Petrović I; Svetel M; Kostić VS
    J Neurol; 2008 Aug; 255(8):1164-7. PubMed ID: 18458857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra.
    Turk KW; Flanagan ME; Josephson S; Keene CD; Jayadev S; Bird TD
    Cerebellum; 2018 Apr; 17(2):143-151. PubMed ID: 28887803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.
    Healy DG; Bressman S; Dickson J; Silveira-Moriyama L; Schneider SA; Sullivan SS; Massey L; Bhatia KP; Shaw K; Bhatia KP; Bomanji J; Wood NW; Lees AJ
    Mov Disord; 2009 Jun; 24(8):1245-7. PubMed ID: 19260103
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
    Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
    Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17.
    Salvatore E; Varrone A; Sansone V; Nolano M; Bruni AC; De Rosa A; Santoro L; Pappatà S; Filla A; De Michele G
    Mov Disord; 2006 Jun; 21(6):872-5. PubMed ID: 16532453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.